跳至主要内容
临床试验/ACTRN12621001449820
ACTRN12621001449820尚未招募未知

Pharmacokinetic profile and breastmilk excretion of sugammadex in pregnant women

Dr Anthony Hodge0 个研究点目标入组 15 人开始时间: 2021年10月25日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 50 Years(—)
性别
Female

入选标准

  • Pregnant women aged greater than or equal to 18 years and less than or equal to 50 years
  • Scheduled for elective caesarean section under general anaesthesia
  • Informed consent by patient to participate in study and to store specimens for immediate and future analysis.

排除标准

  • ¦Known or suspected allergy to sugammadex (urticaria, anaphylaxis, other systemic consequences)
  • ¦Known or suspected allergy to rocuronium
  • ¦Renal impairment – serum creatinine > 70 µmol.L-1
  • ¦Patients with fulminant hepatic failure – confirmed by the presence of hepatic encephalopathy, coagulopathy in the presence of liver enzyme derangement or profound hypoglycaemia
  • ¦Patients receiving fusidic acid, toremifene and/or flucloxacillin, as these drugs have the potential to displace rocuronium from the sugammadex/rocuronium complex

研究者

发起方
Dr Anthony Hodge

相似试验